search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
CLINICAL OPERATIONS & OUTSOURCING


“Try and cultivate a team with diverse backgrounds. In clinical trials issues will always arise and, as a company, if you can draw on various insights from people who have experience in different areas that will enable you to resolve any developing problems in a timely manner”


the sponsor does not identify someone internally to manage the CRO. Firstly, it is essential that sponsors choose a sponsor representative with appropriate experience to provide CRO oversight to ensure the company achieves their goals. Secondly, try and cultivate a team with


diverse backgrounds. In clinical trials issues will always arise and, as a company, if you can draw on various insights from people who have experience in different areas that will enable you to resolve any developing problems in a timely manner. Another reason why it is important to assign one manager per trial is to provide excellent customer service. It is important to have a 24 to 48-hour response turnaround to any questions or issues that arise at clinical sites. That will allow you to maintain the clinical site’s interest in your trial and study timelines.


CTA: Could you provide a real-life example of dealing with an underperforming vendor?


RN: With one company, we decided to conduct certain aspects of a clinical trial in-house for a small, Phase Ib oncology trial at two clinical sites. ore specifically, the sponsor condcted clinical trial management and monitoring in-house, and outsourced data management to a small, local group. The data management group had limited experience in oncology and resources. As a result, study timelines were extended to resolve all data queries at the clinical sites prior to database lock. The sponsor also realised that it was a lot of wor  maintaining the trial master file T,


24 | Outsourcing In Clinical Trials


monitoring and developing standard operating procedures (SOPs) – to conduct clinical trials in-house with limited staff. At the time, the company had budgetary constraints, but no matter how small or the phase of the trial, you require all types of skillsets in the various departments (medical, regulatory, clinical trial management, project management, data management, etc) to successfully conduct a clinical trial. So, it’s best for small companies to outsource to full-service CROs. In the long run, you will save time and money.


CTA: Lastly, what advice would you give to another small company dealing with similar resourcing issues while conducting complex studies?


RN: It is critical to have the right people in place who are knowledgeable in managing clinical trials prior to hiring a CRO. You need to develop your clinical resourcing plan, based on the clinical phase of your company. For example, when a company progresses


from Phase I to Phase II, quality assurance (QA) is very important, especially for manufacturing and product development. Moving forward into Phase II, and potentially Phase III, regulatory becomes a priority. Based on the clinical phase of your company, you need to hire the appropriate resources well in advance of proceeding to the next phase.


To follow-up with Rita Nigam with any questions or concerns, she can be reached at ritanigam20@gmail.com.


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72